BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2017258)

  • 1. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
    Rivière Y; Blank V; Kourilsky P; Israël A
    Nature; 1991 Apr; 350(6319):625-6. PubMed ID: 2017258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.
    Schmid RM; Perkins ND; Duckett CS; Andrews PC; Nabel GJ
    Nature; 1991 Aug; 352(6337):733-6. PubMed ID: 1876189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.
    Watanabe M; Muramatsu M; Hirai H; Suzuki T; Fujisawa J; Yoshida M; Arai K; Arai N
    Oncogene; 1993 Nov; 8(11):2949-58. PubMed ID: 8414497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome.
    Rousset R; Desbois C; Bantignies F; Jalinot P
    Nature; 1996 May; 381(6580):328-31. PubMed ID: 8692272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
    Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
    Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells.
    Harhaj EW; Maggirwar SB; Sun SC
    Oncogene; 1996 Jun; 12(11):2385-92. PubMed ID: 8649779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
    Naumann M; Nieters A; Hatada EN; Scheidereit C
    Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells.
    Thieblemont N; Haeffner-Cavaillon N; Haeffner A; Cholley B; Weiss L; Kazatchkine MD
    J Immunol; 1995 Nov; 155(10):4861-7. PubMed ID: 7594489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection.
    Moriuchi H; Moriuchi M; Fauci AS
    J Immunol; 1997 Apr; 158(7):3483-91. PubMed ID: 9120310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
    Harhaj E; Blaney J; Millhouse S; Sun SC
    Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
    Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
    J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.
    Antoni BA; Rabson AB; Kinter A; Bodkin M; Poli G
    Virology; 1994 Aug; 202(2):684-94. PubMed ID: 7913275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
    Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
    Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic lead activates NF-kappa B in primary human CD4+ T lymphocytes.
    Pyatt DW; Zheng JH; Stillman WS; Irons RD
    Biochem Biophys Res Commun; 1996 Oct; 227(2):380-5. PubMed ID: 8878524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
    Bachelerie F; Alcami J; Arenzana-Seisdedos F; Virelizier JL
    Nature; 1991 Apr; 350(6320):709-12. PubMed ID: 2023633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NF-kappa B activation in human T-cell lines by anetholdithiolthione.
    Sen CK; Traber KE; Packer L
    Biochem Biophys Res Commun; 1996 Jan; 218(1):148-53. PubMed ID: 8573121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type 1 protease activation of NF-kappa B within T lymphoid cells.
    Zhang D; Zhang N; Wick MM; Byrn RA
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):223-30. PubMed ID: 7742037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.